drug

(dexamethasone + tobramycin)

Marketedupdated 2mo ago

by $HROW HARROW, INC.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 19, 2027

~1.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Aug 3, 2028formulationUS 77953162.1y
Dec 19, 2027formulationUS 81015821.5y
Dec 19, 2027formulationUS 84502871.5y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 58m ago

Found something off?

🐶 often sniffed alongside

top 4